Sudeep Pharma IPO Day 1: Check Subscription Status & Key Highlights
The public subscription window for Sudeep Pharma IPO is opening today on November 21, 2025. The bidding window will remain open till November 25, 2025 and the allotment process is expected to be finalised the following day, i.e., November 26, 2025.
Sudeep Pharma Ltd is a manufacturer of excipients and speciality ingredients for the pharmaceutical, food, and nutrition industries. The company supplies its products to domestic and international markets across various regions, such as the United States (US), Europe, South America, the Middle East, Africa, and the Asia-Pacific. The shares of Sudeep Pharma Ltd will be listed on both NSE and BSE with a tentative listing date of November 28, 2025.
Sudeep Pharma IPO Details
Sudeep Pharma IPO is a book build issue of ₹895 crores. The issue is a combination of fresh issue of 0.16 crore shares aggregating to ₹95 crores and an offer for sale (OFS) of 1.35 crore shares aggregating to ₹800 crores. The IPO price band is set between ₹563 to ₹593 per share . The lot size for an application is 25 and the minimum amount of investment required by an retail investor is ₹14,825 (25 shares) based on upper price.
ICICI Securities Limited and IIFL Capital Services Limited (formerly known as IIFL Securities Limited) are the book-running lead managers for the IPO. MUFG Intime India Private Limited (formerly known as Link Intime India Private Limited) is the registrar for the issue.
Sudeep Pharma IPO Day 1 Subscription Status
[November 21, 2025, 11:27 AM]
On Day 1 of subscription, Sudeep Pharma Ltd saw a subscription of 0.42 times as per the NSE data on November 21, 2025, 11:27 a.m. The public issue was subscribed 0.56 times in the Retail Individual Investors (RIIs) category, 0.64 times in the Non Institutional Investors (NII) category and 0 times in the Qualified Institutional Buyers (QIBs) category.
Explore other Upcoming IPOs on BSE and NSE.
Utilisation of Proceeds
The Company will utilise the net proceeds from the fresh issue for the following purposes:
- Capital expenditure towards procurement of machinery for the Company’s production line located at Nandesari Facility I.
- General corporate purposes.
Check out newly Listed IPOs on BSE and NSE.
About Sudeep Pharma Ltd
Sudeep Pharma Limited, incorporated in December 1989 and headquartered at Vadodara, Gujarat, is a manufacturer of mineral-based excipients and specialty ingredients serving the pharmaceutical, food and nutrition industries. The company’s product range includes calcium, magnesium, iron, zinc, potassium and sodium derivatives used as functional ingredients and excipients.
It operates manufacturing facilities in Vadodara (Gujarat) and exports to a wide global base. For the fiscal year ended December 31, 2024, Sudeep Pharma reported revenue from operations of about ₹ 344.45 crore and a net profit of approximately ₹ 94.54 crore.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here